GENG Weihua, LOU Jiaoying, WANG Ying, et al. Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg[J]. Modern Chinese Clinical Medicine, 2023, 30(4): 99-106.
DOI:
GENG Weihua, LOU Jiaoying, WANG Ying, et al. Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg[J]. Modern Chinese Clinical Medicine, 2023, 30(4): 99-106.DOI: 10.3969/j.issn.2095-6606.2023.04.022.
Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg
To investigate the effect and mechanism of Qingdu Suppository (Toxin-Clearing Suppository) on cervical cancer
in vitro
and
in vivo
based on cell apoptosis and immune regulation.
Methods
2
(1) Cell experiment: SiHa cells were divided into blank serum groups at various concentrations (5%
10%
15%
20%
respectively) and dosed serum groups at various concentrations (5%
10%
15%
20%
respectively). The CCK8 method was employed to investigate the effects of different serum concentrations on SiHa cell activity. Flow cytometry was then used to detect the apoptosis and cycle distribution of the cells treated with 15% dosed serum for 72 h. (2) Animal experiment: A tumor bearing mouse model of cervical cancer was established. The mice were divided into cervical cancer control group (PBS buffer gavage)
Qingdu Suppository low-dosage group (14.4 g/kg gavage) and Qingdu Suppository high-dosage group (28.8 g/kg gavage) by random number table method
with 6 mice in each group. The intervention lasted for 28 days. The tumor volume and body weight were recorded. The proliferation and apoptosis of tumor tissues in the three groups were detected via Ki67 assay and Tunel assay
respectively
and the expression of T cell subtypes in tumor tissues of the three groups were detected by flow cytometry.
Results
2
The cell experiment showed that the dosed serum could inhibit the activity of SiHa cells
with the 15% and 20% dosed serum exhibiting the strongest inhibitory effect when the cells were treated for 72 h
and there was no significant difference between the two groups. Compared with the 15% blank serum group
apoptotic cells increased in the 15% dosed serum group. Cells in phase G0/G1 increased and those in phase S and G2/M decreased in dosed serum
the differences were statistically significant (
P
<
0.01). The animal experiment showed that compared with the control group
the proportion of Ki67 positive cells in the tumor tissues of the two Qingdu Suppository groups decreased while Tunel positive cells increased
and the changes in the high-dosage group were more prominent with the differences being statistically significant between the two groups (
P
<
0.01). Compared with the control group
the proportion of Th1 and Th17 cells in peripheral blood of mice in the high-dosage group increased
the proportion of Th2 and Treg cells decreased
and the proportion of Th1/Th2 and Th17/Treg increased
with the differences being statistically significant (
P
<
0.05).
Conclusion
2
The optimal dosage of Qingdu Suppository to inhibit SiHa cell activity is 15% for 72 hours. Qingdu Suppository may inhibit cervical cancer by promoting apoptosis of cancer cells. This may also be achieved by regulating drift of Th2 to Th1
inhibiting Treg cells and relieving immunosuppression through immune microenvironment.
关键词
Keywords
references
COHEN P A , JHINGRAN A , OAKNIN A , et al . Cervical cancer [J]. Lancet , 2019 , 393 ( 10167 ): 169 - 182 .
SMALLEY R C , PELLOM S T , MORILLON II Y M , et al . Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine [J]. J Immunother Cancer , 2020 , 8 ( 1 ): 1 - 12 .
YUAN Y , CAI X , SHEN F , et al . HPV post-infection microenvironment and cervical cancer [J/OL]. Cancer Lett , 2021 , 497 : 243 - 254 [ 2022-04-01 ]. https://doi.org/10.1016/j.canlet.2020.10.034 https://doi.org/10.1016/j.canlet.2020.10.034 .
DOGAN S , TERZIOGLU E , UCAR S . Innate immune response against HPV:possible crosstalking with endocervical γδT cells [J/OL]. J Reprod Immunol , 2021 , 11 ( 148 ): 103435 [ 2022-04-01 ]. https://doi.org/10.1016/j.jri.2021.103435 https://doi.org/10.1016/j.jri.2021.103435 .
MATTHEWS H K , BERTOLI C , DE BRUIN R A . Cell cycle control in cancer [J]. Nat Rev Mol Cell Biol , 2022 , 23 ( 1 ): 74 - 88 .
MENS M M J , GHANBARI M . Cell cycle regulation of stem cells by microRNAs [J]. Stem Cell Rev Rep , 2018 , 14 ( 3 ): 309 - 322 .
GAO S W , LIU F . Novel insights into cell cycle regulation of cell fate determination [J]. J Zhejiang Univ-Sc B , 2019 , 20 ( 6 ): 467 - 475 .
XU X , LAI Y , HUA Z C . Apoptosis and apoptotic body: disease message and therapeutic target potentials [J]. Biosci Rep , 2019 , 39 ( 1 ): 1 - 17 .
ZHU X , ZHU J . CD4 T helper cell subsets and related human immunological disorders [J]. Int J Mol Sci , 2020 , 21 ( 21 ): 1 - 26 .
DONG C . Cytokine regulation and function in T cells [J]. Annu Rev Immunol , 2021 , 10 ( 39 ): 51 - 76 .
LIN W , NIU Z , ZHANG H , et al . Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer [J]. IJCEP , 2019 , 12 ( 9 ): 3604 - 3612 .